FYERS
Home
/
Stocks
/
Balance Sheet
/
Glenmark Pharmaceuticals Balance Sheet

Glenmark Pharmaceuticals Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)2,275.00
Volume (₹)2.58 L
High (₹)2,286.40
Upper Circuit2,323.30
Low (₹)2,242.00
Lower Circuit2,188.10
Prev Close2,265.30
52W High (₹)2,537.60
Price2,246.00
52W Low (₹)1,792.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)63980.30 Cr
Div. Yield (%)0.11
PE Ratio35.59
Debt to Equity0.00
Price to Book5.75
Book Value371.30
EPS (TTM)63.70
Face Value1.00
ROE (%)14.10

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
GLENMARKNSE
LTP
1W Low
1W High
Market cap (₹)
1746.4-13.6 (-0.77%)
1725.50
1776.60
4,24,466Cr
9023-317 (-3.39%)
8937.50
9431.50
2,46,222Cr
4580-76.9 (-1.65%)
4551.80
4682
1,76,301Cr
1124.7+7.2 (0.64%)
1107.30
1150.90
1,12,818Cr
2036.9+0.3 (0.01%)
2007.80
2069.20
1,10,823Cr
1314.6+13.6 (1.05%)
1300.20
1333.30
1,07,447Cr
1216+19 (1.59%)
1196.90
1250.70
1,03,471Cr
2335-33.5 (-1.41%)
2317.50
2426.80
97,850Cr
1662.9-30.1 (-1.78%)
1654.10
1715
96,836Cr
1953.2-3.3 (-0.17%)
1925.70
1964.90
89,629Cr
2246-47 (-2.05%)
2242
2293.90
63,980Cr

Key Highlights of Glenmark Pharmaceuticals Ltd Balance Sheet

Glenmark Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹28.22Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹28.22Cr, and the reserves and surplus of the company is ₹24117Cr.

The company has its non-current liabilities with total liabilities of ₹34216.1Cr as of 2026-03-31.

The current liabilities are ₹3669.03Cr as of 2026-03-31. At the same time, current assets are ₹6095.1Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹15202.2Cr and tangible assets of ₹2027.9Cr, provided in the Glenmark Pharmaceuticals Ltd financial statements.